A 68 residue N-terminal fragment of pro-atrial natriuretic peptide is a monomeric intrinsically unstructured protein

被引:3
|
作者
Crimmins, Dan L. [1 ]
Kao, Jeffrey L. -F. [2 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA
[2] Washington Univ, Dept Chem, High Resolut NMR Facil, St Louis, MO 63130 USA
来源
JOURNAL OF BIOCHEMISTRY | 2011年 / 150卷 / 02期
关键词
atrial natriuretic peptide; intrinsically unstructured protein; monomer; natriuretic peptide; N-terminal atrial natriuretic peptide; GLYCOSYLATION; PRECURSOR; SPECTRA; REGIONS; PROBNP; BNP;
D O I
10.1093/jb/mvr046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mature pro forms of the cardiac natriuretic peptides, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), are proteolytically processed to their active hormone forms (28 and 32 residues, respectively) and N-terminal (NT)-pro fragments (68 and 76 residues, respectively). Far-ultraviolet circular dichroism (UV CD), 1D and 2D-homonuclear nuclear magnetic resonance (NMR), size exclusion-high performance liquid chromatography (SE-HPLC) and analytical ultracentrifuge sedimentation equilibrium (AUCSE) data are obtained for NT-proANP. CD data showed a large negative molar ellipticity for NT-proANP of -14,800 degrees cm(2)/dmol at 199-200 nm. The intensity of the 1D-H-1 NMR spectra in the amide region for NT-proANP was very low and confined to similar to 8-8.6 ppm. Furthermore, cross-correlation resonance peaks were absent in the corresponding 2D-H-1 NOE spectra for NT-proANP in this region. The elution peak for this fragment from a G2000SW size-exclusion column was 20.4'; myoglobin (similar to 17 K) was also eluted at 20.4'. No higher molecular weight oligomers were evident in the AUCSE experiments for NT-proANP. Collectively, the physical data demonstrate that NT-proANP, like NT-proBNP, is primarily a disordered, monomeric protein. Lastly, we compare the predictions from two in silico metaserver disorder algorithms, MeDor and MetaPrDOS, to the experimental data.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [21] N-terminal pro-atrial natriuretic peptide response to acute exercise in depressed patients and healthy controls
    Krogh, Jesper
    Stroehle, Andreas
    Westrin, Asa
    Klausen, Tobias
    Jorgensen, Martin Balslev
    Nordentoft, Merete
    PSYCHONEUROENDOCRINOLOGY, 2011, 36 (05) : 656 - 663
  • [22] Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
    Omland, T
    de Lemos, JA
    Morrow, DA
    Antman, EN
    Cannon, CP
    Hall, C
    Braunwald, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (04): : 463 - +
  • [23] Association between glomerular filtration rate and plasma N-terminal pro-atrial natriuretic peptide concentration in dogs
    Ogawa, M.
    Nohara, H.
    Hsu, H. h.
    Ishizaka, M.
    Miyagawa, Y.
    Takemura, N.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2023, 64 (09) : 568 - 573
  • [24] N-terminal pro-atrial natriuretic peptide is a marker for coronary and peripheral artery disease in type 2 diabetes
    Hermans, M. P.
    Ahn, S. A.
    Gruson, D.
    Ketelslegers, J. M.
    Rousseau, M. F.
    EUROPEAN HEART JOURNAL, 2006, 27 : 530 - 530
  • [25] Plasmatic levels of N-terminal pro-atrial natriuretic peptide in preeclamptic patients and healthy normotensive pregnant women
    Reyna-Villasmil, Eduardo
    Mejia-Montilla, Jorly
    Reyna-Villasmil, Nadia
    Mayner-Tresol, Gabriel
    Herrera-Moya, Pedro
    Fernandez-Ramirez, Andreina
    Rondon-Tapia, Marta
    MEDICINA CLINICA, 2018, 150 (09): : 336 - 340
  • [26] Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea
    Eckstein, Jens
    Potocki, Mihael
    Murray, Karsten
    Breidthardt, Tobias
    Ziller, Ronny
    Mosimann, Tamina
    Klima, Theresia
    Hoeller, Rebeca
    Moehring, Berit
    Sou, Seoung Mann
    Gimenez, Maria Rubini
    Morgenthaler, Nils G.
    Mueller, Christian
    HEART, 2012, 98 (20) : 1518 - 1522
  • [27] Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure
    von Haehling, Stephan
    Jankowska, Ewa A.
    Morgenthaler, Nils G.
    Vassanelli, Corrado
    Zanolla, Luisa
    Rozentryt, Plotr
    Filippatos, Gerasimos S.
    Doehner, Wolfram
    Koehler, Friedrich
    Papassotiriou, Jana
    Kremastinos, Dimitrios T.
    Banasiak, Waldemar
    Struck, Joachim
    Ponikowski, Piotr
    Bergmann, Andreas
    Anker, Stefan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (20) : 1973 - 1980
  • [28] Plasma concentration of N-terminal pro-atrial and N-terminal pro-brain natriuretic peptides and fluid balance in children with bronchiolitis
    Daneshmand, K. Alex
    Zaritsky, Arno L.
    Lamb, Melissa A.
    LeVine, Ann Marie
    Theriaque, Douglas W.
    Sanders, Ronald C., Jr.
    JOURNAL OF PEDIATRIC INTENSIVE CARE, 2012, 1 (03) : 143 - 151
  • [29] Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide
    Jarai, R
    Iordanova, N
    Jarai, R
    Raffetseder, A
    Woloszczuk, W
    Gyöngyösi, M
    Geyer, G
    Wojta, J
    Huber, K
    EUROPEAN HEART JOURNAL, 2005, 26 (03) : 250 - 256
  • [30] N-TERMINAL PRO ATRIAL-NATRIURETIC-PEPTIDE IN HUMAN PLASMA
    BUCKLEY, MG
    SAGNELLA, GA
    MARKANDU, ND
    SINGER, DRJ
    MACGREGOR, GA
    AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (12) : 933 - 935